Inhibition of autophagy with bafilomycin and chloroquine decreases mitochondrial quality and bioenergetic function in primary neurons

Redox Biology

Volumn 11, Issue , 2017, Pages 73-81

  Redmann, Matthew ^a   Benavides, Gloria A ^a   Berryhill, Taylor F ^b   Wani, Willayat Y ^a   Ouyang, Xiaosen ^a   Johnson, Michelle S ^a   Ravi, Saranya ^a   Barnes, Stephen ^b   Darley Usmar, Victor M ^a   Zhang, Jianhua ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN A1; CHLOROQUINE; CITRATE SYNTHASE; MITOCHONDRIAL DNA; LC3 PROTEIN, RAT; MACROLIDE; MICROTUBULE ASSOCIATED PROTEIN;

ANIMAL CELL; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BIOENERGY; BRAIN CELL; CITRIC ACID CYCLE; CONTROLLED STUDY; DNA DAMAGE; DRUG MECHANISM; EMBRYO; LYSIS; METABOLISM; METABOLOMICS; MITOCHONDRION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECTS; ENERGY METABOLISM; GENETICS; LYSOSOME; PROCEDURES;

ANIMALS; AUTOPHAGY; CHLOROQUINE; DNA DAMAGE; DNA, MITOCHONDRIAL; ENERGY METABOLISM; LYSOSOMES; MACROLIDES; METABOLOMICS; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIA; NEURONS; RATS;

EID: 84997531342     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2016.11.004     Document Type: Article

References (54)

1. [1] Dodson, M., Darley-Usmar, V., Zhang, J., Cellular metabolic and autophagic pathways: traffic control by redox signaling. Free Radic. Biol. Med. 63 (2013), 207–221.
2. [2] Lee, J., Giordano, S., Zhang, J., Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 441:2 (2012), 523–540.
3. [3] Yorimitsu, T., Klionsky, D.J., Autophagy: molecular machinery for self-eating. Cell Death Differ. 12:Suppl 2 (2005), 1542–1552.
4. [4] Klionsky, D.J., Emr, S.D., Autophagy as a regulated pathway of cellular degradation. Science 290:5497 (2000), 1717–1721.
5. [5] Zhang, J., Autophagy and mitophagy in cellular damage control. Redox Biol. 1:1 (2013), 19–23.
6. [6] Zhang, J., Teaching the basics of autophagy and mitophagy to redox biologists-mechanisms and experimental approaches. Redox Biol. 4 (2015), 242–259.
7. [7] Slater, A.F., Cerami, A., Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355:6356 (1992), 167–169.
8. [8] Trape, J.F., Pison, G., Preziosi, M.P., Enel, C., Desgrees du Lou, A., Delaunay, V., Samb, B., Lagarde, E., Molez, J.F., Simondon, F., Impact of chloroquine resistance on malaria mortality. C. R. Acad. Sci. III 321:8 (1998), 689–697.
9. [9] Kimura, T., Takabatake, Y., Takahashi, A., Isaka, Y., Chloroquine in cancer therapy: a double-edged sword of autophagy. Cancer Res. 73:1 (2013), 3–7.
10. [10] Hook, G., Jacobsen, J.S., Grabstein, K., Kindy, M., Hook, V., Cathepsin B is a new drug target for traumatic brain injury therapeutics: evidence for E64d as a promising lead drug candidate. Front. Neurol., 6, 2015, 178.
11. [11] Hook, G., Hook, V., Kindy, M., The cysteine protease inhibitor, E64d, reduces brain amyloid-beta and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, beta-secretase activity. J. Alzheimers Dis. 26:2 (2011), 387–408.
12. [12] Hook, G., Yu, J., Toneff, T., Kindy, M., Hook, V., Brain pyroglutamate amyloid-beta is produced by cathepsin B and is reduced by the cysteine p inhibitor E64d, representing a potential Alzheimer's disease therapeutic. J. Alzheimers Dis. 41:1 (2014), 129–149.
13. [13] Klionsky, D.J., Abdalla, F.C., Abeliovich, H., Abraham, R.T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J.A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8:4 (2012), 445–544.
14. [14] Wu, J.J., Quijano, C., Chen, E., Liu, H., Cao, L., Fergusson, M.M., Rovira, I.I., Gutkind, S., Daniels, M.P., Komatsu, M., et al. Mitochondrial dysfunction and oxidative stress mediate the physiological impairment induced by the disruption of autophagy. Aging 1:4 (2009), 425–437.
15. [15] Bowman, E.J., Siebers, A., Altendorf, K., Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl. Acad. Sci. U.S.A. 85:21 (1988), 7972–7976.
16. [16] Werner, G., Hagenmaier, H., Drautz, H., Baumgartner, A., Zahner, H., Metabolic products of microorganisms. 224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity. J. Antibiot., 37(2), 1984 (110–17).
17. [17] Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., Tashiro, Y., Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem. 266:26 (1991), 17707–17712.
18. [18] Yamamoto, A., Tagawa, Y., Yoshimori, T., Moriyama, Y., Masaki, R., Tashiro, Y., Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 23:1 (1998), 33–42.
19. [19] Klionsky, D.J., Elazar, Z., Seglen, P.O., Rubinsztein, D.C., Does bafilomycin A1 block the fusion of autophagosomes with lysosomes?. Autophagy 4:7 (2008), 849–850.
20. [20] Teplova, V.V., Tonshin, A.A., Grigoriev, P.A., Saris, N.E., Salkinoja-Salonen, M.S., Bafilomycin A1 is a potassium ionophore that impairs mitochondrial functions. J. Bioenerg. Biomembr. 39:4 (2007), 321–329.
21. [21] Zhdanov, A.V., Dmitriev, R.I., Papkovsky, D.B., Bafilomycin A1 activates respiration of neuronal cells via uncoupling associated with flickering depolarization of mitochondria. Cell Mol. Life Sci. 68:5 (2011), 903–917.
22. [22] Ochiai, H., Sakai, S., Hirabayashi, T., Shimizu, Y., Terasawa, K., Inhibitory effect of bafilomycin A1, a specific inhibitor of vacuolar-type proton pump, on the growth of influenza A and B viruses in MDCK cells. Antivir. Res. 27:4 (1995), 425–430.
23. [23] Yeganeh, B., Ghavami, S., Kroeker, A.L., Mahood, T.H., Stelmack, G.L., Klonisch, T., Coombs, K.M., Halayko, A.J., Suppression of influenza A virus replication in human lung epithelial cells by noncytotoxic concentrations bafilomycin A1. Am. J. Physiol. Lung Cell. Mol. Physiol. 308:3 (2015), L270–L286.
24. [24] Hernandez-Breijo, B., Monserrat, J., Roman, I.D., Gonzalez-Rodriguez, A., Fernandez-Moreno, M.D., Lobo, M.V., Valverde, A.M., Gisbert, J.P., Guijarro, L.G., Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1. Toxicol. Appl. Pharmacol. 272:3 (2013), 568–578.
25. [25] Ohta, T., Arakawa, H., Futagami, F., Fushida, S., Kitagawa, H., Kayahara, M., Nagakawa, T., Miwa, K., Kurashima, K., Numata, M., et al. Bafilomycin A1 induces apoptosis in the human pancreatic cancer cell line Capan-1. J. Pathol. 185:3 (1998), 324–330.
26. [26] Lim, J.H., Park, J.W., Kim, M.S., Park, S.K., Johnson, R.S., Chun, Y.S., Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha. Mol. Pharmacol. 70:6 (2006), 1856–1865.
27. [27] Homewood, C.A., Warhurst, D.C., Peters, W., Baggaley, V.C., Lysosomes, pH and the anti-malarial action of chloroquine. Nature 235:5332 (1972), 50–52.
28. [28] Chaanine, A.H., Gordon, R.E., Nonnenmacher, M., Kohlbrenner, E., Benard, L., Hajjar, R.J., High-dose chloroquine is metabolically cardiotoxic by inducing lysosomes and mitochondria dysfunction in a rat model of pressure overload hypertrophy. Physiol. Rep., 3, 2015, 7.
29. [29] Zhang, J., Darley-Usmar, V., Reeve, A.K., Krishnan, K.J., Duchen, M.R., Turnbull, D.M., (eds.) Mitochondrial Dysfunction in Neurodegenerative Disorders, 2012, Springer, London, 95–111.
30. [30] Mitchell, T., Chacko, B., Ballinger, S.W., Bailey, S.M., Zhang, J., Darley-Usmar, V., Convergent mechanisms for dysregulation of mitochondrial quality control in metabolic disease: implications for mitochondrial therapeutics. Biochem. Soc. Trans. 41:1 (2013), 127–133.
31. [31] Redmann, M., Dodson, M., Boyer-Guittaut, M., Darley-Usmar, V., Zhang, J., Mitophagy mechanisms and role in human diseases. Int. J. Biochem. Cell Biol. 53 (2014), 127–133.
32. [32] Hill, B.G., Benavides, G.A., Lancaster, J.R. Jr., Ballinger, S., Dell'Italia, L., Jianhua, Z., Darley-Usmar, V.M., Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biol. Chem. 393:12 (2012), 1485–1512.
33. [33] Butow, R.A., Avadhani, N.G., Mitochondrial signaling: the retrograde response. Mol. Cell. 14:1 (2004), 1–15.
34. [34] Goldenthal, M.J., Marin-Garcia, J., Mitochondrial signaling pathways: a receiver/integrator organelle. Mol. Cell. Biochem. 262:1–2 (2004), 1–16.
35. [35] Gupta, S., Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). Int. J. Oncol. 22:1 (2003), 15–20.
36. [36] Fetterman, J.L., Pompilius, M., Westbrook, D.G., Uyeminami, D., Brown, J., Pinkerton, K.E., Ballinger, S.W., Developmental exposure to second-hand smoke increases adult atherogenesis and alters mitochondrial DNA copy number and deletions in apoE(-/-) mice. PloS One, 8(6), 2013, e66835.
37. [37] Schneider, C.A., Rasband, W.S., Eliceiri, K.W., NIH image to ImageJ: 25 years of image analysis. Nat. Methods 9:7 (2012), 671–675.
38. [38] Giordano, S., Dodson, M., Ravi, S., Redmann, M., Ouyang, X., Darley Usmar, V.M., Zhang, J., Bioenergetic adaptation in response to autophagy regulators during rotenone exposure. J. Neurochem., 2014.
39. [39] Boyer-Guittaut, M., Poillet, L., Liang, Q., Bole-Richard, E., Ouyang, X., Benavides, G.A., Chakrama, F.Z., Fraichard, A., Darley-Usmar, V.M., Despouy, G., et al. The role of GABARAPL1/GEC1 in autophagic flux and mitochondrial quality control in MDA-MB-436 breast cancer cells. Autophagy 10:6 (2014), 986–1003.
40. [40] Schapira, A.H., Gegg, M., Mitochondrial contribution to Parkinson's disease pathogenesis. Park. Dis., 2011, 2011, 159160.
41. [41] Knight-Lozano, C.A., Young, C.G., Burow, D.L., Hu, Z.Y., Uyeminami, D., Pinkerton, K.E., Ischiropoulos, H., Ballinger, S.W., Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 105:7 (2002), 849–854.
42. [42] Dranka, B.P., Benavides, G.A., Diers, A.R., Giordano, S., Zelickson, B.R., Reily, C., Zou, L., Chatham, J.C., Hill, B.G., Zhang, J., et al. Assessing bioenergetic function in response to oxidative stress by metabolic profiling. Free Radic. Biol. Med. 51:9 (2011), 1621–1635.
43. [43] Salabei, J.K., Gibb, A.A., Hill, B.G., Comprehensive measurement of respiratory activity in permeabilized cells using extracellular flux analysis. Nat. Protoc. 9:2 (2014), 421–438.
44. [44] Smith, M.R., Vayalil, P.K., Zhou, F., Benavides, G.A., Beggs, R.R., Golzarian, H., Nijampatnam, B., Oliver, P.G., Smith, R.A., Murphy, M.P., et al. Mitochondrial thiol modification by a targeted electrophile inhibits metabolism in breast adenocarcinoma cells by inhibiting enzyme activity and protein levels. Redox Biol. 8 (2016), 136–148.
45. [45] Mizushima, N., Yoshimori, T., How to interpret LC3 immunoblotting. Autophagy 3:6 (2007), 542–545.
46. [46] Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., Yoshimori, T., LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19:21 (2000), 5720–5728.
47. [47] Benavides, G.A., Liang, Q., Dodson, M., Darley-Usmar, V., Zhang, J., Inhibition of autophagy and glycolysis by nitric oxide during hypoxia-reoxygenation impairs cellular bioenergetics and promotes cell death in primary neurons. Free Radic. Biol. Med. 65 (2013), 1215–1228.
48. [48] Dodson, M., Liang, Q., Johnson, M.S., Redmann, M., Fineberg, N., Darley-Usmar, V.M., Zhang, J., Inhibition of glycolysis attenuates 4-hydroxynonenal-dependent autophagy and exacerbates apoptosis in differentiated SH-SY5Y neuroblastoma cells. Autophagy, 9, 2013, 12.
49. [49] Hjelmeland, A., Zhang, J., Metabolic, autophagic, and mitophagic activities in cancer initiation and progression. Biomed. J. 39:2 (2016), 98–106.
50. [50] Liang, Q., Benavides, G.A., Vassilopoulos, A., Gius, D., Darley-Usmar, V., Zhang, J., Bioenergetic and autophagic control by Sirt3 in response to nutrient deprivation in mouse embryonic fibroblasts. Biochem. J. 454:2 (2013), 249–257.
51. [51] Redmann, M., Darley-Usmar, V., Zhang, J., The role of autophagy, mitophagy and lysosomal functions in modulating bioenergetics and survival in the context of redox and proteotoxic damage: implications for neurodegenerative diseases. Aging Dis. 7:2 (2016), 150–162.
52. [52] Wang, Z., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., Dugar, B., Feldstein, A.E., Britt, E.B., Fu, X., Chung, Y.M., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472:7341 (2011), 57–63.
53. [53] Wang, Z., Tang, W.H., Cho, L., Brennan, D.M., Hazen, S.L., Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition. Arterioscler Thromb. Vasc. Biol. 29:9 (2009), 1383–1391.
54. [54] Chouchani, E.T., Pell, V.R., Gaude, E., Aksentijevic, D., Sundier, S.Y., Robb, E.L., Logan, A., Nadtochiy, S.M., Ord, E.N., Smith, A.C., et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515:7527 (2014), 431–435.